A rapidly emerging clinical application of positron emission tomography (PET) is the
detection and staging of cancer with the glucose analogue tracer 2-[fluorine-18]fluoro-2-deoxy-d-…

… approximately 4 y until the final clinical diagnosis and an additional average of 5 y until death
… are similar to longitudinal clinical diagnosis over approximately 4 y (39). Furthermore, the …

Imaging plays an essential role in identifying intracranial injury in patients with traumatic brain
injury (TBI). The goals of imaging include (1) detecting injuries that may require immediate …

Treatment is complex for patients with head and neck (H&N) cancers with specific site of
disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning …

… Amplification of the 16S rRNA coding region of the DNA and sequencing of the 16S
rDNA were performed as described by Anzai et al. (1997). The 16S rDNA sequences were …

… system and the representation it employs are discussed from an artificial intelligence
viewpoint in Anzai (1978a), and computational results are described in detail in Anzai (1978b). …

Purpose: To analyze the patterns of local-regional recurrence in patients with head and
neck cancer treated with parotid-sparing conformal and segmental intensity-modulated …

The 16S rRNA sequences of Chryseomonas luteola, the type species of the genus
Chryseomonas, and Flavimonas oryzihabitans, the type species of the genus Flavimonas, were …

Although computed tomography and magnetic resonance imaging have contributed to the
ability to identify metastatic disease in head and neck Cancer, inadequacies in evaluating …

PURPOSE: To determine the safety and efficacy of ferumoxtran 10–enhanced magnetic
resonance (MR) imaging for diagnosis of metastases to lymph nodes and the clinical usefulness …